semaglutide percentage weight loss These retrospective tirzepatide data from our friends at the @mayoclinic are consistent with trial data for both tirzepatide and consistently show greater relative (percentage) in women compared to men The headlines about GLP-1s and

Ignore blood sugar and heart health, offering zero metabolic benefits

Herein, we successfully switched a patient with acromegaly from a DPP-4 inhibitor to a GLP-1 analog due to pasireotide-induced deterioration of glycemic control

M., Patel, R., & George, R

A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes

A highly glycolytic or pro-angiogenic product may worsen edema, vascular permeability, or ectopic tissue responses

1,2 While outcome in intensively treated individuals was superior to those undergoing standard therapy, of concern was the weight gain and increased risk of hypoglycemia